Contracts › 75N93021F00001
75N93021F00001: Decorporation Mcm Phase 1 Clinical Safety Study
Awarded to Sri International by National Institutes of Health (NIH).
$9.8Mobligated
$9.8Mpotential value
30 April 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75N93021F00001 |
|---|---|
| Vehicle | 75N93020D00011 |
| Awardee | Sri International |
| Awarding agency | National Institutes of Health (NIH) |
| Awarding office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | AN12 Health R&D Services; Health Care Services; Applied Research |
| Place of performance | CA |
| Period of performance | 01 September 2021 to 30 April 2027 |
| Potential end | 30 April 2027 |
| Estimated recompete solicitation | ~Q4 2026 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 04 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record